Technical advances,especially in the field of biotechnology, have led to the development ofseveral next generation preventive vaccines, including recombinant vaccines,viral vector based vaccines and DNA vaccines, which have been demonstrated toelicit powerful immune responses, resulting in the development of immunologicalmemory.
To order this 250+ page report, which features 85+ figuresand 125+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/preventive-vaccines/318.html
The USD 94 billion(by 2030) financial opportunity within the global preventive vaccine market hasbeen analyzed across the following segments:
§ Route of Administration
§ Intramuscular
§ Subcutaneous
§ Oral
§ Intravenous
§ Others
§ Type of Vaccine
§ Pneumococcal Conjugate Vaccine
§ Human Papilloma Virus Vaccine
§ Rotavirus Vaccine
§ Influenza Vaccine
§ MMR Vaccine
§ Tetanus and Diphtheria Booster Vaccine
§ Varicella Vaccine
§ DTaP-Hib-IPV Vaccine
§ DTaP-HepB-Hib-IPV Vaccine
§ Others
§ Type of Vaccine API
§ Live, Attenuated Vaccine
§ Inactivated Vaccine
§ Conjugate Vaccine
§ Subunit Vaccine
§ Toxoid Vaccine
§ Others
§ Target Patient Population
§ Pediatric Patients
§ Adults
§ Key Players
§ GlaxoSmithKline
§ Merck
§ Sanofi Pasteur
§ Pfizer
§ Emergent BioSolutions
§ CSL
§ Others
§ Key Geographical Regions
§ North America
§ Europe
§ Asia Pacific
§ Rest of the World
The GlobalPreventive Vaccines Market, 2020-2030” report features thefollowing companies, which we identified to be key players in this domain:
§ Bio Farma
§ Emergent BioSolutions
§ GC Pharma
§ GlaxoSmithKline
§ Janssen
§ Merck
§ Novavax
§ Pfizer
§ Sanofi Pasteur
§ Valneva
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Market Landscape
5. Company Competitiveness Analysis
6. Company Profiles
7. Clinical Trial Analysis
8. Ongoing Vaccine Development Initiatives for ComplexConditions
9. Funding and Investment Analysis
10. Market Sizing and Opportunity Analysis
11. Case-in-Point: Contract Manufacturing of Vaccines
12. Concluding Remarks
13. Executive Insights
14. Appendix 1: Tabulated Data
15. Appendix 2: List of Companies and Organizations
To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/preventive-vaccines/318.html
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
